Case Study: Boehringer Ingelheim improves stroke-risk hospital targeting with Definitive Healthcare

Boehringer Ingelheim boosts stroke risk estimate to nearly 90% with Definitive Healthcare

The cardiovascular division of Boehringer Ingelheim, a large biopharma company, needed to accurately segment accounts and tailor sales messaging by determining the percentage of high-risk stroke patients at target hospitals. They previously relied on an untrusted national estimate of 70%. To solve this challenge, they partnered with Definitive Healthcare for its data and analytics services.

Definitive Healthcare implemented a solution using current claims data to provide hospital-level visibility into the patient population. This analysis revealed that most hospitals were well above the 70% estimate, with many closer to 90%. The results provided by Definitive Healthcare enabled the sales team to confidently prioritize high-value accounts and tailor their messaging, significantly increasing the precision of their outreach and credibility with customers.

Boehringer Ingelheim